![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 27, 2023 1:22:20 PM
But, that is our reality. It's a reality made even worse by shareholders who fault management for the strategic positioning of the company on the Expert Market, and they don't even try to understand why management would this, not even when reason is before them.
In my opinion, the only material weakness or reportable event relevant to us has been our negligently-delayed authorization from the FDA and NIH/NIAID, which by now could have caused millions of preventable deaths worldwide, since our EUA application was submitted.
Nevertheless, I think management's strategic positioning of the company will prove successful, and will enable the use of lenzilumab to help stamp out covid and certain cancers. You would think health regulators would want that.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM